SCHEMBL6168721

SCHEMBL6168721

CC1(c2ccc(Oc3ccccc3)cc2)NC(=S)N(Cc2ccccc2)C1=O

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 4/20 0.54
ALDH1A1 P00352 2/20 0.48
LMNA P02545 1/20 0.48
GAA P10253 1/20 0.48
HDAC6 Q9UBN7 1/20 0.46
ELANE P08246 1/20 0.44
MMP2 P08253 2/20 0.43
MMP9 P14780 2/20 0.43
MMP3 P08254 1/20 0.43
MMP8 P22894 1/20 0.43
MMP13 P45452 1/20 0.43
TP53 P04637 1/20 0.43
TSHR P16473 1/20 0.43
CYP2C19 P33261 2/20 0.42
DRD2 P14416 1/20 0.42
HTR7 P34969 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7486579 0.88 CNR1 (0.59) CNR1ALDH1A1LMNAGAAHDAC6
SCHEMBL6169138 0.83 CNR1 (0.49) CNR1ALDH1A1LMNAGAAMMP2
SCHEMBL6167711 0.79 CNR1 (0.50) CNR1ALDH1A1LMNAGAAMMP2
SCHEMBL6170816 0.77 MEN1 (0.47) CNR1ALDH1A1GAATSHRMEN1
SCHEMBL6169070 0.75 FAAH (0.50) CNR1ALDH1A1LMNAGAAMMP2
SCHEMBL6168870 0.75 GAA (0.46) CNR1ALDH1A1LMNAGAAMMP2
SCHEMBL6169738 0.74 CNR1 (0.43) CNR1ALDH1A1LMNAGAAMMP2
SCHEMBL6835850 0.72 MMP2 (0.50) ALDH1A1LMNAGAAMMP2MMP9
SCHEMBL6168712 0.72 CNR1 (0.46) CNR1ALDH1A1GAAMMP2MMP9
SCHEMBL6168079 0.71 LMNA (0.47) CNR1ALDH1A1LMNAMMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546111-A2 2-THIOHYDANTOINE DERIVATIVE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF DIABETES LABORATOIRES FOURNIER S.A. (FR) 2005-06-29 EP disclosed
WO-2004031160-A2 2-THIOHYDANTOINE DERIVATIVE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF DIABETES LABORATOIRES FOURNIER S.A. (FR) 2004-04-15 WO disclosed